|
LETM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.23679999575188E-08 |
| Normal-vs-Stage3 |
1.83431048128568E-12 |
| Normal-vs-Stage4 |
5.03749999491987E-08 |
| Stage1-vs-Stage2 |
6.703200E-01 |
| Stage1-vs-Stage3 |
3.329000E-01 |
| Stage1-vs-Stage4 |
4.135000E-01 |
| Stage2-vs-Stage3 |
3.151400E-01 |
| Stage2-vs-Stage4 |
3.616800E-01 |
| Stage3-vs-Stage4 |
8.647000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6242562850266E-12 |
| Normal-vs-AfricanAmerican |
1.12243547789603E-13 |
| Normal-vs-Asian |
3.67749999999889E-05 |
| Caucasian-vs-AfricanAmerican |
9.298200E-01 |
| Caucasian-vs-Asian |
4.974400E-01 |
| AfricanAmerican-vs-Asian |
5.428200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.75049974515673E-11 |
| Male-vs-Female |
2.959400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.57969209829889E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
6.66133814775094E-16 |
| Normal-vs-Extreme_Obese |
5.659300E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.119400E-01 |
| Normal_Weight-vs-Obese |
8.747400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.032500E-02 |
| Extreme_Weight-vs-Obese |
2.880600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.933700E-02 |
| Obese-vs-Extreme_Obese |
8.063800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.25449994836657E-09 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.38160002830057E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.721600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.318800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.912600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.060400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.365400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.756410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.33457697618178E-12 |
| Normal-VS-KIRP CIMP |
3.70469999122491E-09 |
| Normal-VS-Unclassified PRCC |
6.16640072337304E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.964600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.699900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.692600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.056300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.289800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.067560E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55431223447522E-15 |
| Normal-vs-N1 |
3.26090043856198E-10 |
| Normal-vs-N2 |
1.234510E-04 |
| N0-vs-N1 |
9.654000E-01 |
| N0-vs-N2 |
5.899600E-01 |
| N1-vs-N2 |
6.738000E-01 |
|
|
